MarketPeel
Insider Trading Intelligence
Pricing
…
KM

Kristina Masson

ACRV
EVP - BUSINESS OPERATIONS · ACRIVON THERAPEUTICS, INC. · CIK 0001950501
FILING MIX · LIFETIME37%/63%
BUYS
15
SELLS
26
TOTAL VALUE
$2.19M
COMPANIES
1
ACTIVE SINCE
Nov 2022
HOLDINGS NOW
2,245,317
AVG SELL PX
$4.27
TRADE KIND
SHOWING 41 / 41
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Kristina Masson, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+14.21%-0.72%+14.93%+14.93%—
14d1+100.00%+3.28%+0.73%+2.55%+2.55%—
30d1+0.00%-10.93%-1.25%-9.68%-9.68%—
60d1+0.00%-7.10%-3.09%-4.01%-4.01%—
90d1+0.00%-10.38%+0.59%-10.98%-10.98%—
180d1(1 pending)——————
1y1(1 pending)——————
2y1(1 pending)——————
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ACRV · 2,245,317 shares · as of May 21, 2026
0605,6281,211,2571,816,8852,422,5132023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 15 buys / 26 sellsCOVERAGE · 15 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
13,729$1.79$24.6K2,245,317May 21, 2026May 26, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
72,706——386,343May 18, 2026May 20, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
180,095——2,259,046May 18, 2026May 20, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
1,253$1.92$2.4K2,078,951May 14, 2026May 18, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
490$1.92$941313,637May 14, 2026May 18, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
185,495——185,495Mar 1, 2026Mar 3, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
417,210——417,210Mar 1, 2026Mar 3, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
14,265$1.53$21.8K2,080,204Feb 21, 2026Feb 24, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
1,302$1.63$2.1K2,094,469Feb 14, 2026Feb 18, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
579$1.63$944314,127Feb 14, 2026Feb 18, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASE
EVP - Business Operations
49,000$1.68$82.1K2,095,771Jan 14, 2026Jan 16, 2026 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
19,904$2.30$45.8K2,046,771Nov 21, 2025Nov 25, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
59,765$2.24$133.9K2,066,675Nov 14, 2025Nov 18, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
490$2.24$1.1K314,706Nov 14, 2025Nov 18, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
19,905$1.32$26.3K2,126,440Aug 21, 2025Aug 25, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
490$1.39$681315,196Aug 14, 2025Aug 18, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
59,766$1.39$83.1K2,146,345Aug 14, 2025Aug 18, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
19,904$1.15$22.9K2,206,111May 21, 2025May 23, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
491$1.14$560315,686May 14, 2025May 16, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
59,766$1.14$68.1K2,226,015May 14, 2025May 16, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
390,390——390,390Mar 1, 2025Mar 4, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
140,540——140,540Mar 1, 2025Mar 4, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
19,904$5.54$110.3K2,285,781Feb 21, 2025Feb 25, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
37,152$5.42$201.4K2,305,685Feb 14, 2025Feb 19, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
579$5.42$3.1K316,177Feb 14, 2025Feb 19, 2025 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
19,910$6.44$128.2K2,342,837Nov 21, 2024Nov 25, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
59,766$7.92$473.3K2,362,747Nov 14, 2024Nov 18, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
490$7.92$3.9K316,756Nov 14, 2024Nov 18, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
79,616$9.19$731.7K2,422,513Aug 21, 2024Aug 23, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
490$7.02$3.4K317,246Aug 14, 2024Aug 16, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
490$8.36$4.1K317,736May 14, 2024May 16, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
225,226——225,226Mar 1, 2024Nov 27, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
90,090——90,090Mar 1, 2024Nov 27, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
579$3.40$2.0K318,226Feb 14, 2024Feb 16, 2024 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
SALE
EVP - Business Operations
1,900$5.08$9.7K318,805Nov 14, 2023Nov 16, 2023 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
503,419——2,310,007Nov 14, 2022Nov 16, 2022 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
180,269——180,269Nov 14, 2022Nov 16, 2022 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
80,120——80,120Nov 14, 2022Nov 16, 2022 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,090——2,370,097Nov 14, 2022Nov 16, 2022 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
934,731——1,806,588Nov 14, 2022Nov 16, 2022 ↗View →
ACRV
ACRIVON THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
26,707——320,705Nov 14, 2022Nov 16, 2022 ↗View →
Other insiders · ACRV
Loading peer insiders…
About this filer
CIK 0001950501
ROLE
EVP - Business Operations
PRIMARY
ACRV
COMPANIES
1
ACTIVE SINCE
Nov 2022
MARKETPEEL · /INSIDER/0001950501DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback